What is the incidence of Escherichia coli sepsis in the neonatal intensive care unit, overall and for early‑onset (≤ 72 hours) versus late‑onset (≥ 72 hours) neonatal sepsis, particularly among preterm (< 32 weeks gestation) or very‑low‑birth‑weight (< 1500 g) infants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

E. coli Sepsis Incidence in the NICU

E. coli is the leading cause of early-onset sepsis in preterm and very low birth weight infants in the NICU, with incidence rates of approximately 18.5 per 1,000 live births in extremely preterm neonates (22-28 weeks gestation) and rising significantly over the past two decades. 1

Overall Incidence by Gestational Age

The incidence of E. coli sepsis varies dramatically by gestational age and birth weight:

  • Extremely preterm infants (22-28 weeks): 18.47 per 1,000 live births 1
  • Very low birth weight infants (<1,500g): 8.68 per 1,000 live births, representing a significant increase from 5.07 per 1,000 in 2006-2009 1
  • All gestational ages combined: E. coli accounts for approximately 36.6% of all early-onset sepsis cases 1

Early-Onset vs. Late-Onset Disease

E. coli demonstrates distinct patterns based on timing of infection:

  • Early-onset sepsis (≤72 hours): E. coli is the predominant pathogen, particularly in preterm infants, with 68 of 131 cases (51.9%) occurring in this population 1
  • Late-onset sepsis (>72 hours): E. coli accounts for approximately 83% of cases in some NICU cohorts, though this varies by institution 2
  • Onset timing: 63% of E. coli early-onset sepsis presents on the first day of life 3

Geographic and Setting Variations

In low- and lower-middle-income countries, the burden is substantially higher:

  • LLMICs: E. coli accounts for 15% of all Gram-negative neonatal sepsis cases 4
  • NICU-specific data: 49 of 88 studies from LLMICs were conducted in NICUs, showing Gram-negative organisms (including E. coli) cause 60% of neonatal sepsis 4

Critical Risk Factors Associated with E. coli Sepsis

The following maternal and neonatal factors significantly increase E. coli sepsis risk:

  • Preterm premature rupture of membranes (PPROM): 74% of E. coli cases vs. 11% of non-E. coli sepsis 3
  • Prolonged rupture of membranes (>24 hours): 47% of E. coli cases 3
  • Intrapartum fever: 26% of E. coli cases vs. 4% of non-E. coli sepsis 3
  • Gestational age <30 weeks: 47% of E. coli cases vs. 4% of non-E. coli sepsis 3

Alarming Resistance Patterns

A critical pitfall is assuming standard ampicillin-gentamicin therapy remains effective, as resistance has increased dramatically:

  • Ampicillin resistance: 79-93% of E. coli isolates in recent studies 5, 3
  • Gentamicin resistance: 16-60% of isolates, with higher rates in preterm infants (60% vs. 9.4% in term infants) 6, 2
  • Dual resistance (ampicillin + gentamicin): 7.8% of isolates, rendering first-line therapy completely ineffective 1
  • Third-generation cephalosporin resistance: Increased from 14.3% to 46.7% over recent decades 6
  • ESBL production: 66.7% in preterm infants vs. 15.6% in term infants 6

Mortality Outcomes

The mortality burden falls disproportionately on preterm infants:

  • Preterm infants (<37 weeks): 29% mortality rate 1
  • Very low birth weight infants: 35.3% mortality rate 5
  • Term infants: No deaths reported in recent surveillance 1

Clinical Presentation

Avoid the pitfall of waiting for classic sepsis signs—93.6% of E. coli sepsis cases display illness within 72 hours of birth, requiring immediate empiric treatment after cultures are obtained. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.